Published Date: 17 Mar 2023
Bladder cancer is not a rare disease. It is one of the 10 most common cancers in the UK and the 5th most common cancer in the European Union.
Read Full NewsEli Lilly said on Wednesday its weight-loss drug, Zepbound, used with psoriasis treatment Taltz, showed better results in patients with the skin disease and obesity in a...
Patients with moderate‑to‑severe plaque psoriasis achieve greater relief from itching, skin pain, and scaling with bimekizumab vs secukinumab up to 3 years.
Treatment with amivantamab is associated with a broad spectrum of dermatologic adverse events that can be severe in patients with non-small cell lung cancer, a real-world study shows.
South Carolina reported a surge to 962 measles cases on Tuesday, state health data showed, including 12 additional infections since Friday, as officials warned the widening...
As currently written, the instructions could potentially lead to delayed treatment of high glucose levels.
An expansion of higher-level neonatal care has been observed in urban hospitals in the US over the years, whereas rural hospitals have faced a decline in such care capacity, per a recent study.
1.
Eliminating the SRC-3 gene in immune cells causes an efficient, long-lasting anti-cancer response.
2.
Medical Journal March 28, 2023
3.
Routine MRI scans detect cancers in asymptomatic patients with rare genetic condition
4.
New Zealand and Australian breast cancer rates among the highest in the world, global study finds
5.
Providing essential cancer care to rural communities
1.
Therapeutic Innovations Through Germline Predisposition in Acute Leukemias and Myeloid Neoplasms
2.
Essential Oncology Updates: Diagnosis, Treatment Advances, Tools & Education Resources
3.
Unraveling the Mystery of Non-Caseating Granulomas: A Comprehensive Guide
4.
A Revolutionary Guide to Calculating Absolute Neutrophil Counts
5.
Understanding Purpura Fulminans: Causes, Symptoms and Treatment Options
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III
2.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII
4.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
5.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation